Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain, Postoperative, Abdominoplasty

In brief

This is a multicenter, randomized, double-blind, placebo-controlled efficacy and safety study of the INL-001 (bupivacaine HCl) implant, at 300 mg, in patients following abdominoplasty to evaluate postoperative analgesia.

Key facts

Study ID
NCT04785625
Run by
Innocoll
People needed
366
Starts
2021-04-29
Expected to finish
2021-10-27
Last updated by the study team
2022-11-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.